GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: GTI-2040|DRUG: capecitabine
Sponsor: National Cancer Institute (NCI)